{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:58:09Z","timestamp":1770839889758,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clae.2023.101873","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T14:56:41Z","timestamp":1687791401000},"page":"101873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A systematic review and meta-analysis on the efficacy of topical povidone iodine in adenoviral conjunctivitis"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-2630","authenticated-orcid":false,"given":"Julio","family":"Gonz\u00e1lez Mart\u00edn-Moro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Zarallo-Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4448-9293","authenticated-orcid":false,"given":"Elena","family":"Guzm\u00e1n-Almagro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ant\u00f3n Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clae.2023.101873_b0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY)"},{"issue":"5","key":"10.1016\/j.clae.2023.101873_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.survophthal.2015.04.001","article-title":"Adenoviral keratoconjunctivitis","volume":"60","author":"Jhanji","year":"2015","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2023.101873_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0035-9203(92)90328-A","article-title":"Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan","volume":"86","author":"Woodland","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.clae.2023.101873_b0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.oftal.2012.07.007","article-title":"Adenoviral keratoconjunctivitis: an update","volume":"88","author":"Gonz\u00e1lez-L\u00f3pez","year":"2013","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"2","key":"10.1016\/j.clae.2023.101873_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/v13020293","article-title":"Adenovirus and the cornea: more than meets the eye","volume":"13","author":"Rajaiya","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.clae.2023.101873_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8023361","article-title":"Impact of the COVID-19 lockdown on ophthalmological assistance in the emergency department at a spanish primary level hospital","volume":"2021","author":"Gonz\u00e1lez-Mart\u00edn-Moro","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.clae.2023.101873_b0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/OPTH.S233486","article-title":"Direct and indirect costs of infectious conjunctivitis in a commercially insured population in the United States","volume":"14","author":"Pepose","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2023.101873_b0040","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1177\/1120672120957581","article-title":"Epidemiology of pseudomembranous conjunctivitis in a tertiary hospital: a 2-year retrospective study","volume":"31","author":"de-Arriba-Palomero","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2023.101873_b0045","article-title":"A new paradigm in the treatment of adenoviral conjunctivitis?","volume":"94","author":"Gonz\u00e1lez-Mart\u00edn-Moro","year":"2019","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"1","key":"10.1016\/j.clae.2023.101873_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone-iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clae.2023.101873_b0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ajo.2016.10.004","article-title":"Prospective, randomized clinical trial of povidone-iodine 1.25% solution versus topical antibiotics for treatment of bacterial keratitis","volume":"176","author":"Isenberg","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2023.101873_b0060","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 Cochrane, 2022."},{"issue":"5","key":"10.1016\/j.clae.2023.101873_b0065","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9394(02)01701-4","article-title":"A controlled trial of povidone-iodine to treat infectious conjunctivitis in children","volume":"134","author":"Isenberg","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2023.101873_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/15569527.2014.888077","article-title":"Povidone iodine in the treatment of adenoviral conjunctivitis in infants","volume":"34","author":"\u00d6zen Tunay","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"issue":"8","key":"10.1016\/j.clae.2023.101873_b0075","first-page":"968","article-title":"The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis","volume":"66","author":"Yazar","year":"2016","journal-title":"J Pak Med Assoc"},{"issue":"9","key":"10.1016\/j.clae.2023.101873_b0080","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Curr Eye Res"},{"issue":"8","key":"10.1016\/j.clae.2023.101873_b0085","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clae.2023.101873_b0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2018.05.012","article-title":"Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"194","author":"Pepose","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2023.101873_b0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/OPTH.S191275","article-title":"A randomized controlled trial of povidone-iodine\/dexamethasone ophthalmic suspension for acute viral conjunctivitis","volume":"13","author":"Pepose","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2023.101873_b0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41433-020-01344-6","article-title":"Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a prospective randomized controlled study","volume":"36","author":"Ricciardelli","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clae.2023.101873_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ajo.2019.02.039","article-title":"Controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"205","author":"Pepose","year":"2019","journal-title":"Am J Ophthalmol United States"},{"issue":"9","key":"10.1016\/j.clae.2023.101873_b0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1017\/ice.2018.145","article-title":"Five-year trends in adenoviral conjunctivitis in employees of one medical center","volume":"39","author":"Kuo","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.clae.2023.101873_b0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/08164622.2021.1877532","article-title":"Povidone iodine for the treatment of adenoviral conjunctivitis","volume":"104","author":"Dang","year":"2021","journal-title":"Clin Exp Optom"},{"issue":"3","key":"10.1016\/j.clae.2023.101873_b0120","article-title":"Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis","volume":"2022","author":"Liu","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.clae.2023.101873_b0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/OPX.0000000000001691","article-title":"Success of masking 5% povidone-iodine treatment: the reducing adenoviral patient infected days study","volume":"98","author":"Whiteside","year":"2021","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"issue":"Pt 1","key":"10.1016\/j.clae.2023.101873_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.clae.2023.101873_b0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/jop.2018.0122","article-title":"The in vitro evaluation of povidone-iodine against multiple ocular adenoviral types","volume":"35","author":"Yates","year":"2019","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048423000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048423000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T01:20:58Z","timestamp":1761268858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048423000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1367048423000875"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2023.101873","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis on the efficacy of topical povidone iodine in adenoviral conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2023.101873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101873"}}